CytoSorbents Corp
CytoSorbents Corp logo
CTSO

CytoSorbents Corp (CTSO)

$1.397.95%

Live
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$1.39
Day's Range
$1.5
$1.18
52-Week Range
$5.4
1 month return13.22%
3 month return25.98%
1 year return70.04%
5 year return78.58%

Company Information

CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 66 countries around the world, as an extracorporeal cytokine adsorber designed to reduce the “cytokine storm” or “cytokine release syndrome” that could otherwise cause massive inflammation, organ failure and death in common critical illnesses. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure. CytoSorb® has been used in more than 110,000 human treatments to date. CytoSorb has received CE-Mark label expansions for the removal of bilirubin (liver disease), myoglobin (trauma) and both ticagrelor and rivaroxaban during cardiothoracic surgery. CytoSorb has also received FDA Emergency Use Authorization in the United States for use in critically ill COVID-19 patients with imminent or confirmed respiratory failure, in defined circumstances. CytoSorb has also been granted FDA Breakthrough Designation for the removal of ticagrelor in a cardiopulmonary bypass circuit during emergent and urgent cardiothoracic surgery. CytoSorbents’ purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its technologies have received non-dilutive grant, contract, and other funding of more than $38 million from DARPA, the U.S. Department of Health and Human Services (HHS), the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), the U.S. Army, the U.S. Air Force, U.S. Special Operations Command (SOCOM), Air Force Material Command (USAF/AFMC), and others. The Company has numerous products under development based upon this unique blood purification technology protected by many issued U.S. and international patents and multiple applications pending, including ECOS-300CY™, CytoSorb-XL™, HemoDefend-RBC™, HemoDefend-BGA™, VetResQ™, K+ontrol™, ContrastSorb, DrugSorb, and others.
OrganizationCytoSorbents Corp
Employees221
CEODr. Phillip P. Chan M.D., Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 5 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 5 Wall street analysts offering stock ratings for CytoSorbents Corp(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 421.58%

Current

$1.39

Target

$7.25

Recommendation Trend

Based on 5 analyst

Current1M Ago3M Ago
Buy
5
9
9
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
64.1M
Book Value
$0.9
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.68
PEG Ratio
0.0
Wall Street Target Price
7.25

Valuation

Trailing PE0.0
Forward PE106.38
Price/Book (mrq)
1.63
Enterprise Value
54.5M
Enterprise Value/Revenue
1.74
Enterprise Value/Ebitda
-1.64

Technicals

Beta
0.7
50 Day MA
1.6
200 Day MA
2.27

Institutional Holdings

Skylands Capital, LLC

5.38%

Avenir Corporation

4.96%

Vanguard Group Inc

4.48%

Granahan Investment Management Inc..

3.46%

Neuberger Berman Group LLC

3.39%

Sargent Investment Group, LLC

2.54%

Discover more

Frequently Asked Questions

What is CytoSorbents Corp share price today?

Can Indians buy CytoSorbents Corp shares?

How can I buy CytoSorbents Corp shares from India?

Can Fractional shares of CytoSorbents Corp be purchased?

What are the documents required to start investing in CytoSorbents Corp stocks?

What are today’s High and Low prices of CytoSorbents Corp?

What are today’s traded volumes of CytoSorbents Corp?

What is today’s market capitalisation of CytoSorbents Corp?

What is the 52 Week High and Low Range of CytoSorbents Corp?

How much percentage CytoSorbents Corp is down from its 52 Week High?

How much percentage CytoSorbents Corp is up from its 52 Week low?

What are the historical returns of CytoSorbents Corp?

Who is the Chief Executive Officer (CEO) of CytoSorbents Corp?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*